Suppr超能文献

病毒RNA突变具有区域特异性,且在全长丙型肝炎病毒复制系统中会因利巴韦林而增加。

Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system.

作者信息

Contreras Ana Maria, Hiasa Yoichi, He Wenping, Terella Adam, Schmidt Emmett V, Chung Raymond T

机构信息

Gastrointestinal Unit, Massachusetts General Hospital and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02114, USA.

出版信息

J Virol. 2002 Sep;76(17):8505-17. doi: 10.1128/jvi.76.17.8505-8517.2002.

Abstract

High rates of genetic variation ensure the survival of RNA viruses. Although this variation is thought to result from error-prone replication, RNA viruses must also maintain highly conserved genomic segments. A balance between conserved and variable viral elements is especially important in order for viruses to avoid "error catastrophe." Ribavirin has been shown to induce error catastrophe in other RNA viruses. We therefore used a novel hepatitis C virus (HCV) replication system to determine relative mutation frequencies in variable and conserved regions of the HCV genome, and we further evaluated these frequencies in response to ribavirin. We sequenced the 5' untranslated region (5' UTR) and the core, E2 HVR-1, NS5A, and NS5B regions of replicating HCV RNA isolated from cells transfected with a T7 polymerase-driven full-length HCV cDNA plasmid containing a cis-acting hepatitis delta virus ribozyme to control 3' cleavage. We found quasispecies in the E2 HVR-1 and NS5B regions of untreated replicating viral RNAs but not in conserved 5' UTR, core, or NS5A regions, demonstrating that important cis elements regulate mutation rates within specific viral segments. Neither T7-driven replication nor sequencing artifacts produced these nucleotide substitutions in control experiments. Ribavirin broadly increased error generation, especially in otherwise invariant regions, indicating that it acts as an HCV RNA mutagen in vivo. Similar results were obtained in hepatocyte-derived cell lines. These results demonstrate the potential utility of our system for the study of intrinsic factors regulating genetic variation in HCV. Our results further suggest that ribavirin acts clinically by promoting nonviable HCV RNA mutation rates. Finally, the latter result suggests that our replication model may be useful for identifying agents capable of driving replicating virus into error catastrophe.

摘要

高遗传变异率确保了RNA病毒的生存。尽管这种变异被认为是由易出错的复制导致的,但RNA病毒也必须维持高度保守的基因组片段。为了使病毒避免“错误灾难”,保守和可变的病毒元件之间的平衡尤为重要。利巴韦林已被证明能在其他RNA病毒中诱导错误灾难。因此,我们使用一种新型丙型肝炎病毒(HCV)复制系统来确定HCV基因组可变区和保守区的相对突变频率,并进一步评估这些频率对利巴韦林的反应。我们对从转染了含有顺式作用丁型肝炎病毒核酶以控制3'切割的T7聚合酶驱动的全长HCV cDNA质粒的细胞中分离出的复制性HCV RNA的5'非翻译区(5'UTR)、核心区、E2高变区-1、NS5A和NS5B区进行了测序。我们在未处理的复制性病毒RNA的E2高变区-1和NS5B区发现了准种,但在保守的5'UTR、核心区或NS5A区未发现,这表明重要的顺式元件调节特定病毒片段内的突变率。在对照实验中,T7驱动的复制和测序假象均未产生这些核苷酸替换。利巴韦林广泛增加了错误产生,尤其是在原本不变的区域,表明它在体内作为HCV RNA诱变剂起作用。在肝细胞衍生的细胞系中也获得了类似结果。这些结果证明了我们的系统在研究调节HCV遗传变异的内在因素方面的潜在用途。我们的结果进一步表明,利巴韦林在临床上通过提高无活力的HCV RNA突变率起作用。最后,后一结果表明我们的复制模型可能有助于识别能够使复制病毒陷入错误灾难的药物。

相似文献

2
Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system.
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9847-52. doi: 10.1073/pnas.171319698. Epub 2001 Aug 7.
4
6
The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA.
Virology. 2003 Jun 5;310(2):333-42. doi: 10.1016/s0042-6822(03)00152-1.
9
Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA.
J Viral Hepat. 2004 Nov;11(6):479-87. doi: 10.1111/j.1365-2893.2004.00531.x.

引用本文的文献

1
Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants.
Proc Natl Acad Sci U S A. 2025 Jul 15;122(28):e2500276122. doi: 10.1073/pnas.2500276122. Epub 2025 Jul 9.
3
Selective Depletion of ZAP-Binding CpG Motifs in HCV Evolution.
Pathogens. 2022 Dec 27;12(1):43. doi: 10.3390/pathogens12010043.
4
Atypical Mutational Spectrum of SARS-CoV-2 Replicating in the Presence of Ribavirin.
Antimicrob Agents Chemother. 2023 Jan 24;67(1):e0131522. doi: 10.1128/aac.01315-22. Epub 2023 Jan 5.
6
Preparation of ribavirin analogues by copper- and ruthenium-catalyzed azide-alkyne 1,3-dipolar cycloaddition.
Tetrahedron. 2008 Sep 15;64(38):9044-9051. doi: 10.1016/j.tet.2008.07.007. Epub 2008 Jul 5.
7
Design, synthesis and biological evaluation of 2-aminoquinazolin-4(3H)-one derivatives as potential SARS-CoV-2 and MERS-CoV treatments.
Bioorg Med Chem Lett. 2021 May 1;39:127885. doi: 10.1016/j.bmcl.2021.127885. Epub 2021 Mar 2.
8
Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19).
Front Pharmacol. 2020 Sep 25;11:561334. doi: 10.3389/fphar.2020.561334. eCollection 2020.
9
Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs.
Pathogens. 2020 Apr 26;9(5):320. doi: 10.3390/pathogens9050320.

本文引用的文献

1
Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin.
J Biol Chem. 2001 Dec 7;276(49):46094-8. doi: 10.1074/jbc.C100349200. Epub 2001 Oct 15.
2
Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system.
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9847-52. doi: 10.1073/pnas.171319698. Epub 2001 Aug 7.
3
Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes.
J Virol. 2001 Sep;75(17):8074-81. doi: 10.1128/jvi.75.17.8074-8081.2001.
4
RNA virus error catastrophe: direct molecular test by using ribavirin.
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6895-900. doi: 10.1073/pnas.111085598. Epub 2001 May 22.
6
Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame.
RNA. 2001 May;7(5):710-21. doi: 10.1017/s1355838201010111.
7
Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies.
J Virol. 2001 Apr;75(7):3259-67. doi: 10.1128/JVI.75.7.3259-3267.2001.
9
Efficient initiation of HCV RNA replication in cell culture.
Science. 2000 Dec 8;290(5498):1972-4. doi: 10.1126/science.290.5498.1972.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验